Caricamento...
Therapeutic potential of Fingolimod in triple negative breast cancer preclinical models
Surgery followed by a chemotherapy agent is the first-line treatment for breast cancer patients. Nevertheless, new targets are required for women with triple-negative breast cancer (TNBC) in order to improve the treatment of this aggressive cancer subtype. Multiple pro-inflammatory molecules includi...
Salvato in:
| Pubblicato in: | Transl Oncol |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Neoplasia Press
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7649527/ https://ncbi.nlm.nih.gov/pubmed/33157518 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2020.100926 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|